Xiaohan Zhou

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Diagnostic Value of Serological Markers and Quantitative Real-Time PCR in Patients With Invasive Candidiasis

Diagnostic Value of Serological Markers and Quantitative Real-Time PCR in Patients With Invasive Candidiasis

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: June 15, 2025

Transcriptomic Determinants of Circulating Immunity Predict Immune-Related Adverse Events (irAEs) in Cancer Patients Receiving PD-1/PD-L1 Blockade.

Transcriptomic Determinants of Circulating Immunity Predict Immune-Related Adverse Events (irAEs) in Cancer Patients Receiving PD-1/PD-L1 Blockade.

Journal: Thoracic cancer
Published: June 13, 2025

Circulating immunological transcriptomic profile identifies DDX3Y and USP9Y on the Y chromosome as promising biomarkers for predicting response to programmed death 1/programmed death ligand 1 blockade.

Circulating immunological transcriptomic profile identifies DDX3Y and USP9Y on the Y chromosome as promising biomarkers for predicting response to programmed death 1/programmed death ligand 1 blockade.

Journal: Chinese medical journal
Published: May 15, 2024

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.

Journal: Journal of translational medicine
Published: July 16, 2023

Diverse regulated cell death modes predict the immune microenvironment and drug sensitivity in lung adenocarcinoma.

Diverse regulated cell death modes predict the immune microenvironment and drug sensitivity in lung adenocarcinoma.

Journal: Journal of cellular physiology
Published: June 28, 2023

Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.

Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.

Journal: Precision clinical medicine
Published: December 12, 2021

Identification of potential immune-related circRNA-miRNA-mRNA regulatory network in cutaneous squamous cell carcinoma.

Identification of potential immune-related circRNA-miRNA-mRNA regulatory network in cutaneous squamous cell carcinoma.

Journal: American journal of cancer research
Published: March 25, 2021

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer.

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer.

Journal: Frontiers in oncology
Published: September 09, 2020

Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials.

Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials.

Journal: Journal of cancer research and clinical oncology
Published: July 16, 2020

Improvement of the C-glycosylation Step for the Synthesis of Remdesivir.

Improvement of the C-glycosylation Step for the Synthesis of Remdesivir.

Journal: Organic process research & development
Published: July 01, 2020

Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma.

Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma.

Journal: BMC cancer
Published: May 11, 2020

Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality.

Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality.

Journal: Frontiers in oncology
Published: April 27, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026